guluronic acid has been researched along with Spondylitis, Ankylosing in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mansouri, R; Mirshafiey, A; Nazeri, S; Sadoughi, A | 1 |
| Jafarnezhad-Ansariha, F; Mirshafiey, A; Mortazavi-Jahromi, SS; Nazeri, S; Oraei, M | 1 |
| Afraei, S; Hosseini, M; Jamshidi, AR; Khadem Azarian, S; Mahmoudi, M; Mirshafiey, A; Mostafaei, S; Nazeri, S; Vojdanian, M | 1 |
3 trial(s) available for guluronic acid and Spondylitis, Ankylosing
| Article | Year |
|---|---|
Evaluation of the oral administration of α-l-guluronic acid on COX-1 and COX-2 gene expression profile in ankylosing spondylitis patients.
Topics: Administration, Oral; Adolescent; Adult; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Hexuronic Acids; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Spondylitis, Ankylosing; Transcriptome; Young Adult | 2021 |
Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Forkhead Transcription Factors; GATA3 Transcription Factor; Gene Expression Regulation; Hexuronic Acids; Humans; Immunomodulation; Interleukin-4; Male; Middle Aged; Spondylitis, Ankylosing; Treatment Outcome; Young Adult | 2019 |
The safety and efficacy of Guluronic acid (G2013) in ankylosing spondylitis: A randomized controlled parallel clinical trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Hexuronic Acids; Humans; Inflammation; Male; Naproxen; Spondylitis, Ankylosing; Treatment Outcome | 2019 |